Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Nutrease powder, a high-protein, low-carb supplement, can help manage Polycystic Ovary Syndrome symptoms, regulate periods, improve ovulation, and restore fertility.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Hair loss in postmenopausal woman caused by ovarian issue.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Testosterone reduces key molecules needed for early pregnancy in rats.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Early diagnosis and treatment of PCOS can prevent complications and improve symptoms.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.